Caribou Biosciences is a leading clinical-stage CRISPR genome-editing biopharmaceutical company, dedicated to developing transformative therapies for patients with devastating diseases. Our next-generation genome-editing technology delivers unmatched precision, enabling us to develop cell therapies that are designed to be more effective against a range of serious conditions. We believe the future of cell therapy is off-the-shelf, and we are advancing our pipeline of allogeneic, or "off-the-shelf," cell therapies from our CAR-T cell therapy platform as readily available treatments for patients with hematologic malignancies and autoimmune diseases.
At Caribou Biosciences, we foster a culture where innovative thinking thrives, and diverse perspectives are valued. We are committed to creating an environment where team members are personally engaged, their ideas are taken seriously, and their contributions are recognized. Whether you're working from our headquarters in Berkeley, California, or remotely, you'll be part of a dynamic and supportive community.
Express Your Interest in Future Roles
Are you passionate about the potential of genome-editing technologies and eager to contribute to groundbreaking therapies? If you're interested in joining Caribou Biosciences but don't see a current opening that matches your skills, we'd love to hear from you! Submit your resume and share your career objectives with us. While we may not have an immediate match for every general interest application, we'll keep your information on file and may reach out if a suitable opportunity arises.
To stay up-to-date with our open roles, we encourage you to regularly check our careers page and apply directly to positions that align with your background and experience.
Thank you for your interest in becoming a part of the Caribou herd. We look forward to potentially welcoming you to our team!
What We Do
Caribou is a clinical-stage biopharmaceutical company, founded by pioneers in CRISPR genome editing, leveraging our proprietary technology to develop genome-edited off-the-shelf immune cell therapies for the treatment of cancer. We believe that cell therapies are critical now and for the future of cancer therapy and that advanced genome editing is necessary to develop sophisticated cell therapies to treat a variety of malignancies. We are developing a pipeline of genome-edited, off-the-shelf CAR-T and CAR-NK cell therapies for a range of tumor types.
Our mission is to develop innovative, transformative therapies for patients with devastating diseases through novel genome editing.
Members of the Caribou herd open their minds to new ideas and welcome diverse perspectives. We proudly assert that teams do their best work when their members are personally engaged, their ideas are taken seriously, their contributions are recognized, and their needs are met.
Interested in joining our team? Please check out our jobs at
https://cariboubio.bamboohr.com/jobs/
.png)
